Gene mutation test
This NGS employed targeted capture of exonic and partially intronic regions of eight genes that are recommended by the NCCN guidelines and highly relevant to NSCLC personalized treatment regimens. The 8-gene panel covered oncogenic driver mutations of EGFR, ALK, BRAF, MET, RET, ROS1, ERBB2 and KRAS